Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

GLOX THERAPEUTICS LIMITED

Company number SC760230

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters, selecting an input will reload the page.
Confirmation statement filters, selecting an input will reload the page.

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 Nov 2025 AP01 Appointment of Dr Paul Nicklin as a director on 12 August 2025
View PDF Appointment of Dr Paul Nicklin as a director on 12 August 2025 - link opens in a new window - 2 pages (2 pages)
06 Nov 2025 TM01 Termination of appointment of Niklas Czeloth as a director on 12 August 2025
View PDF Termination of appointment of Niklas Czeloth as a director on 12 August 2025 - link opens in a new window - 1 page (1 page)
06 Nov 2025 TM01 Termination of appointment of James Scott Clark as a director on 26 September 2025
View PDF Termination of appointment of James Scott Clark as a director on 26 September 2025 - link opens in a new window - 1 page (1 page)
12 Sep 2025 AA Accounts for a small company made up to 31 December 2024
View PDF Accounts for a small company made up to 31 December 2024 - link opens in a new window - 9 pages (9 pages)
21 Jul 2025 SH01 Statement of capital following an allotment of shares on 25 March 2025
  • GBP 186.14
View PDF Statement of capital following an allotment of shares on 25 March 2025
  • GBP 186.14
- link opens in a new window - 4 pages (4 pages)
18 Jul 2025 TM02 Termination of appointment of Patricia Barbara Ann Barclay as a secretary on 14 May 2025
View PDF Termination of appointment of Patricia Barbara Ann Barclay as a secretary on 14 May 2025 - link opens in a new window - 1 page (1 page)
26 Mar 2025 CS01 Confirmation statement made on 26 February 2025 with no updates
View PDF Confirmation statement made on 26 February 2025 with no updates - link opens in a new window - 3 pages (3 pages)
06 Feb 2025 AP01 Appointment of Dr Michael Stephen Murray as a director on 6 February 2025
View PDF Appointment of Dr Michael Stephen Murray as a director on 6 February 2025 - link opens in a new window - 2 pages (2 pages)
20 Nov 2024 PSC08 Notification of a person with significant control statement
View PDF Notification of a person with significant control statement - link opens in a new window - 2 pages (2 pages)
17 Sep 2024 AD01 Registered office address changed from , 11 the Square University of Glasgow, University Avenue, Glasgow, G12 8QQ, United Kingdom to John Arbuthnott Building Strathclyde University of Pharmacy & Biomedical 161 Cathedral Street Glasgow G4 0RE on 17 September 2024
View PDF Registered office address changed from , 11 the Square University of Glasgow, University Avenue, Glasgow, G12 8QQ, United Kingdom to John Arbuthnott Building Strathclyde University of Pharmacy & Biomedical 161 Cathedral Street Glasgow G4 0RE on 17 September 2024 - link opens in a new window - 1 page (1 page)
19 Aug 2024 TM01 Termination of appointment of Melville Anderson as a director on 19 August 2024
View PDF Termination of appointment of Melville Anderson as a director on 19 August 2024 - link opens in a new window - 1 page (1 page)
08 Aug 2024 AA Accounts for a small company made up to 31 December 2023
View PDF Accounts for a small company made up to 31 December 2023 - link opens in a new window - 7 pages (7 pages)
22 Mar 2024 CS01 Confirmation statement made on 26 February 2024 with updates
View PDF Confirmation statement made on 26 February 2024 with updates - link opens in a new window - 4 pages (4 pages)
20 Feb 2024 AA01 Previous accounting period shortened from 28 February 2024 to 31 December 2023
View PDF Previous accounting period shortened from 28 February 2024 to 31 December 2023 - link opens in a new window - 1 page (1 page)
18 Jan 2024 AP01 Appointment of Dr Niklas Czeloth as a director on 24 October 2023
View PDF Appointment of Dr Niklas Czeloth as a director on 24 October 2023 - link opens in a new window - 2 pages (2 pages)
18 Jan 2024 AP01 Appointment of Professor Daniel Walker as a director on 24 October 2023
View PDF Appointment of Professor Daniel Walker as a director on 24 October 2023 - link opens in a new window - 2 pages (2 pages)
17 Jan 2024 SH01 Statement of capital following an allotment of shares on 24 October 2023
  • GBP 156.14
View PDF Statement of capital following an allotment of shares on 24 October 2023
  • GBP 156.14
- link opens in a new window - 4 pages (4 pages)
17 Jan 2024 PSC07 Cessation of Daniel Walker as a person with significant control on 24 October 2023
View PDF Cessation of Daniel Walker as a person with significant control on 24 October 2023 - link opens in a new window - 2 pages (2 pages)
09 Jan 2024 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
View PDF Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
- link opens in a new window - 2 pages (2 pages)
09 Jan 2024 MA Memorandum and Articles of Association
View PDF Memorandum and Articles of Association - link opens in a new window - 67 pages (67 pages)
16 May 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
View PDF Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
- link opens in a new window - 1 page (1 page)
16 May 2023 MA Memorandum and Articles of Association
View PDF Memorandum and Articles of Association - link opens in a new window - 34 pages (34 pages)
16 May 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
View PDF Resolutions
  • RES10 ‐ Resolution of allotment of securities
- link opens in a new window - 1 page (1 page)
15 May 2023 PSC07 Cessation of Colin Kleanthous as a person with significant control on 13 April 2023
View PDF Cessation of Colin Kleanthous as a person with significant control on 13 April 2023 - link opens in a new window - 1 page (1 page)
15 May 2023 PSC07 Cessation of G U Holdings Limited as a person with significant control on 12 April 2023
View PDF Cessation of G U Holdings Limited as a person with significant control on 12 April 2023 - link opens in a new window - 1 page (1 page)